Our MIssion
Our mission is to make biotherapeutic drugs more affordable while transforming the economy and strengthening the healthcare offerings within underserved communities around the globe.
Who We Are
We collectively have 100+ Years Experience
formerly working for the following EMPLOYERS:
![Cancer Center Logo[1]_5](https://www.lucaspyebio.com/wp-content/uploads/2020/02/Cancer-Center-Logo1_5-150x150.jpg){kind=logo}
What We Do
As a Contract Development Manufacturing Organization (CDMO), we fast-track the clinical development of your biologic for regulatory approval, manufacture your biologic below market price, and accelerate your drug products into the global commercial market for sale.
LucasPye BIO is the 1st Biologics CDMO with:
- Cloud Software / E-Documentation including Proprietary Mobile/Web Apps
- Prescription Formulary Placement Services including Public/Private Medical Insurers
- Exclusive Partnership with HelaPlex, the 1st Commercial Life Science Co-Working/Wet Lab Facility (Coming Soon in Q4-2022)
LucasPye BIO is 1 of 7 Biologics CDMOs located in the U.S. with capabilities to develop and manufacture Gene/Viral-Based Drug Products.
WHo We Are
Tia Lyles-Williams, MRSc Founder and CEO
As an African-American Queer Woman, Tia Lyles-Williams is the 1st to own & lead a Biotechnology / Biopharmaceutical Large-Scale Manufacturing Company.
Tia is a facilitative leader that is highly knowledgeable about the biotechnology / biopharmaceutical industries & its impact on patients, the middle-class workforce, and economic development in underserved communities. She has twenty (20) years of experience within the industry formerly working for the U.S. Federal Government, Big Pharma and Small Biotech Companies.
LucasPye BIO will be the 2nd African-American owned/lead biotech manufacturing company in the commercial — 65 years after Dr. Percy Lavon Julian and his company, Julian Laboratories, Inc. (1953) in Oak Park, IL — the 1st African-American to own & lead a biotech/biopharma company.
